Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q33637845

about

Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus Type I interferon blockade in systemic lupus erythematosus: where do we stand?Lupus nephritis: the evolving role of novel therapeutics New autoantibody detection technologies yield novel insights into autoimmune disease Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.Type I interferon in the pathogenesis of lupus.Two major autoantibody clusters in systemic lupus erythematosus Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE.Detection of autoantibodies in a point-of-care rheumatology setting.Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency BAFF-ling autoantibodies.Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus.Fueling autoimmunity: type I interferon in autoimmune diseases.Future prospects in biologic therapy for systemic lupus erythematosus.Detection of anti-cytokine antibodies and their clinical relevance.'That Obscure Object of Desire': in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians.Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.Biologic therapies in systemic lupus erythematosus.Sustained remission in lupus nephritis: still a hard road ahead.Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options.Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients.Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.Elevated autoantibodies against interleukin-17F correlate with disease activity in patients with early rheumatoid arthritis.Associations of B cell-activating factor (BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in Singapore.Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis.Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE.Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked.Autoantibodies in SLE: Specificities, Isotypes and Receptors

P2860

Q26785472-066CDC73-71A4-40EE-9DCD-23507EE26002 Q26822662-BC68E1BF-AF6A-45B5-8816-00B35F21AB86 Q26865441-1FC4ABE3-DC93-4C1D-A2B8-1384F8135C29 Q26998390-61E101FB-963B-4CFE-9775-518D36187404 Q27000173-D60A7A56-8F09-4F41-98B9-380FF304AB8B Q27678647-6A7911D4-2552-4E07-B2BA-3413FE026F8F Q28265144-BC1448CC-89A7-4355-B106-B9928E89913C Q33563703-36F404E8-EA60-4262-8152-09B32DC37041 Q33622723-0761F6B2-16A0-4CF4-B032-77E0022A76FB Q33789317-CC2C4645-B70F-476D-8010-009C6B9373C4 Q33852174-824FB3FD-E71D-4463-88A1-23D4CA49C66B Q34171558-4DEE2804-2650-4DCB-81B4-7778F0883A06 Q35112489-86725020-52B8-44B6-BDEB-04FF5AC0F907 Q35233621-A77FA8EE-00B4-44B8-BBBC-5F28AA273AF1 Q35309576-747F0BF6-B03B-4B5D-B1B3-804CA07C816D Q36266446-1885BF45-B9BB-4982-9B29-2444AFD61994 Q37384049-52C9954B-FDCE-4116-9B29-7B0A682B3DAE Q37384057-C21D5AB8-1043-40F0-8BAC-C0EF49015AD1 Q37416120-22C5F997-8271-4AB4-A748-45D88D37C676 Q38135706-A6B2525C-1C0A-442C-8F40-B4346F3B0BB8 Q38217701-3C0C0163-9C88-4348-A16F-52999A16E25B Q38219005-49110B60-2439-412A-A734-2FC1E5846056 Q38237868-9BA2BED3-AFE4-4247-9DDB-3664F6BFC8DD Q38425831-A69421C5-7CCD-4072-AF96-9876B6A9682A Q38641358-4A10F9CD-7735-4162-A731-C64DEC025B50 Q38867891-81584340-7302-4A0F-8FAB-3DE67D7FB663 Q40260152-63A4CC08-BEA1-4D90-B64D-91F5973B60CB Q40265943-2D933F10-5DF9-449F-81F7-2CC2275F512B Q40823594-6C081091-5C4B-42A3-86D5-F6B900C8B576 Q47921621-70F0E135-C6F2-413A-A153-D447A56040C4 Q50091881-CE3264E4-4089-4845-A3FE-8E0AE3867ADB Q51724948-341F9A93-6CA4-4D32-B08D-E1C310843465 Q52719679-A04E7C08-45B6-49C3-9846-0B7260FBA3FC Q56806670-187AA81F-FA58-4B3B-967F-03812199674D

P2860

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q33637845

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Association of endogenous anti ...... systemic lupus erythematosus.

@ast

Association of endogenous anti ...... systemic lupus erythematosus.

@en

type

label

Association of endogenous anti ...... systemic lupus erythematosus.

@ast

Association of endogenous anti ...... systemic lupus erythematosus.

@en

prefLabel

Association of endogenous anti ...... systemic lupus erythematosus.

@ast

Association of endogenous anti ...... systemic lupus erythematosus.

@en

P1433

Q33637845-4A39147A-72C4-4FDD-A56F-5808EFBB5935

P1476

Q33637845-2E68C9CE-C27A-4B24-BDB0-E5D251E887FD

P2093

Q33637845-0E1A77AF-B0F7-4AA6-91A7-DECE3D06758F

Q33637845-2330BC75-5707-471C-A1EA-AFF4FDAEC152

Q33637845-29309816-D14B-42A0-82CF-94889B763B6F

Q33637845-3E327696-E213-4A16-9E12-8EE1C42E7EA5

Q33637845-5B0436A0-F262-413E-8A3A-E37B9EF48F2F

Q33637845-5B6560C8-7EAA-4774-945B-CFF4614DA76A

Q33637845-7EC25AFF-3B43-4C5F-9A17-7D880FB7B920

Q33637845-9BF8B1F7-A4B1-45D4-B89A-F108144DB02C

Q33637845-B15E1BB0-0A83-40DF-8713-F617ADD5C01B

Q33637845-BA8517B9-7618-44E1-B1E1-154B0926F9CD

P2860

Q33637845-0743635D-781F-4E65-9667-19145391B2A6

Q33637845-0ED20F1B-2A34-469A-B69E-C21E6DC48C1F

Q33637845-122DDF97-570D-4054-BE04-7606BC2AB1E8

Q33637845-148C730B-BC89-4B79-920F-FB9F969545B5

Q33637845-1A6F3D25-D4E2-4092-87DD-0ED167196E6D

Q33637845-2583BEC0-5A7D-4A9A-B198-9B5BC536BF25

Q33637845-36306883-03CB-428A-8A65-C799D5E456AD

Q33637845-3D80D10A-8BB9-4677-A932-4E89A7D7945A

Q33637845-413073A2-674D-47D0-9CFB-DE57161E0B0A

Q33637845-4FF7E34B-B64F-445A-B012-3FA0CE956F85

P304

Q33637845-E312DC16-3C76-4ED8-8CE6-C48B2F2D6C87

P31

Q33637845-91497509-4D6E-40B9-8EF0-FE8A36F78912

P356

Q33637845-3E82CB99-DB2D-45D1-8858-183822F21434

P433

Q33637845-ACE1B2F0-1C77-4137-BCC5-1004286F60EB

P478

Q33637845-CA23D846-1E85-4544-9BB1-76AFE49809FD

P577

Q33637845-4F7AE91B-A5E1-48DD-8BC9-4FB49079C442

P5875

Q33637845-DC513A5D-449D-4010-9995-483475F8172B

P698

Q33637845-B662EC17-5709-4C56-9C9A-D0801A641DFE

P921

Q33637845-DCC381ED-80D2-4C06-939D-027475EE52D5

P932

Q33637845-E3BD720A-52DF-45AF-8A98-59C2CD9EDBE7

P356

P1433

Arthritis & Rheumatology

P1476

Association of endogenous anti ...... systemic lupus erythematosus.

@en

P2093

Alexander R Abbas

http://www.w3.org/2001/XMLSchema#string

Alyssa M Morimoto

http://www.w3.org/2001/XMLSchema#string

Ann Brady

http://www.w3.org/2001/XMLSchema#string

Bruce Richardson

http://www.w3.org/2001/XMLSchema#string

Donna Thibault Flesher

http://www.w3.org/2001/XMLSchema#string

Eric Wakshull

http://www.w3.org/2001/XMLSchema#string

Jihong Yang

http://www.w3.org/2001/XMLSchema#string

Kristen Wolslegel

http://www.w3.org/2001/XMLSchema#string

Michael J Townsend

http://www.w3.org/2001/XMLSchema#string

Timothy W Behrens

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

Interferons, interferon-like cytokines, and their receptors

The 1982 revised criteria for the classification of systemic lupus erythematosus

Java Treeview--extensible visualization of microarray data

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.

P304

2407-2415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.30399

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51063681

http://www.w3.org/2001/XMLSchema#string

P698

21506093

http://www.w3.org/2001/XMLSchema#string

P921

P932

4028124

http://www.w3.org/2001/XMLSchema#string